Benedikt von Braunmühl

CEO at Rentschler

Speaker

Benedikt von Braunmühl has been CEO of Rentschler Biopharma since September 2023 and brings to the table a 30-year track record in the global healthcare industry in higher management and executive functions.

He holds a bachelor’s degree in business administration from Lorange Institute of Business (formerly GSBA), Zurich. Prior to joining Rentschler Biopharma, he served as CEO of HMNC Brain Health in Munich, Germany where he transformed a research-focused organization to a clinical-stage biopharma company. Before this, he was Chief Operating Officer Diagnostic Services at Medicover, where he streamlined processes, grew business lines and significantly increased revenue. He previously worked at Qiagen, last serving as Senior VP, Head of Global Commercial Operations and Member of the Executive Committee. In this position, he implemented several transformational projects and drove global commercial growth and efficiency initiatives. He previously was Vice President Latin America & Member of the Americas Management Council at Qiagen. While at Chiron Vaccines (predecessor to Novartis Vaccines & Diagnostics), he established the company’s Latin American regional office to drive commercial growth in that region. He also served as Chairman of the Supervisory Board of Pathoquest and supported that company’s refocusing from a diagnostic company towards a service organization in the biopharma industry.